X-ray computed tomography (CT) is a powerful and widely used medical non-invasive technique that often requires intravenous administration of contrast agents (CAs) to better visualize soft tissues. In this work, we have developed a novel CT contrast agent based on ternary Ag–Au–Se chalcogenide nanoparticles (NP). A facile ligand exchange by using a 3 kDa PEGylated ligand with a dithiol dihydrolipoic acid as an anchor group resulted in highly water-soluble and monodisperse nanoparticles. These PEGylated ternary NPs were tested in vivo in mice, showing slow uptake by the mononuclear phagocyte system, long blood circulation times, low toxicity, and very good X-ray contrast, thus being promising candidates as CT contrast agents for clinical applications.
The optimization of a material functionality requires both the rational design and precise engineering of its structural and chemical parameters. In this work, we show how colloidal chemistry is an excellent synthetic choice for the synthesis of novel ternary nanostructured chalcogenides, containing exclusively noble metals, with tailored morphology and composition and with potential application in the energy conversion field. Specifically, the Ag–Au–Se system has been explored from a synthetic point of view, which leads to a set of Ag2Se-based hybrid and ternary nanoparticles including the room temperature synthesis of the rare ternary Ag3AuSe2fischesserite phase. An in-depth structural and chemical characterization of all nanomaterials has been performed, which proofed especially useful for unravelling the reaction mechanism behind the formation of the ternary phase in solution. The work is complemented with the thermal and electric characterization of a ternary Ag–Au–Se nanocomposite with promising results: we found that the use of the ternary nanocomposite represents a clear improvement in terms of thermoelectric energy conversion as compared to a binary Ag–Se nanocomposite analogue.